CAMPBELL, Calif., March 10, 2021 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, today announces the results of a survey of hospitals and clinics on their opinions about the current state of remote patient monitoring (RPM). Findings unveil significant growth and advancement of RPM technologies throughout the course of the COVID-19 pandemic, and position it for accelerated growth over the next five years.
The survey reveals that nearly half (43 percent) believe RPM adoption will be on par with in-patient monitoring in five years, and 35 percent believe that it will surpass in-patient monitoring in this time frame. Twenty percent of the respondents noted having already adopted RPM, and another 23 percent plan to adopt within 12 months. When it comes to remote data collection, 90 percent of the respondents indicated that continuous, 24-hour data is important when compared to episodic data.
The biggest challenge to adoption is cost, and 55 percent of respondents believe that reimbursement is essential to the overall success of RPM. Another requirement to consider is electronic health record (EHR) integration, which 65 percent of respondents said is essential to widespread adoption.
The COVID pandemic has been an accelerator in the growth of the RPM market, with the majority of respondents (55 percent) answering that they are using or plan to use RPM for COVID-19 patient monitoring. Another important factor to this adoption is that nearly three-quarters of respondents (72 percent) say that patients are hesitant to visit a hospital or doctor’s office in-person.
“COVID-19 has accelerated the demand for remote patient monitoring, as evidenced by the rapid adoption we have seen over the past year,” said Jiang Li, CEO of VivaLNK. “Even with the increased adoption, we are aware that there are still challenges in the market. Proactively addressing these challenges will allow us to provide the best and most cost-effective solution for RPM adoption.”
VivaLNK offers an array of wearable medical sensors and data services to power the world of RPM and telemedicine for more than 90 digital healthcare technology partners in 22 countries worldwide. For more information on VivaLNK’s sensors and services, visit www.vivalnk.com.
About VivaLNK
VivaLNK is a provider of connected healthcare solutions for remote patient monitoring. We leverage unique physiology-optimized medical wearable sensors and data services to enable a deeper and more clinical relationship between provider and patient.
Media Contact
pr@vivalnk.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/more-than-three-quarters-of-hospitals-anticipate-remote-patient-monitoring-to-match-or-surpass-in-patient-within-five-years-301244169.html
SOURCE VivaLNK
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…
SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…
EX Program by Truth Initiative Offers a Proven Path to Success WASHINGTON, Dec. 23, 2024…